Baillie Gifford & Co
OM icon

Baillie Gifford & Co’s Outset Medical OM Stock Holding History

Baillie Gifford & Co’s Portfolio OM Stock Details OM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-26
Closed -$7.1K – 395
2023
Q1 		$7.1K Buy
26
+6
+30% +$2.2K ﹤0.01% 410
2022
Q4 		$7.9K Hold
20
– – ﹤0.01% 427
2022
Q3 		$5K Hold
20
– – ﹤0.01% 447
2022
Q2 		$5K Sell
20
-3
-13% -$1.29K ﹤0.01% 454
2022
Q1 		$16K Hold
23
– – ﹤0.01% 393
2021
Q4 		$16K Hold
23
– – ﹤0.01% 404
2021
Q3 		$17K Hold
23
– – ﹤0.01% 390
2021
Q2 		$17K Hold
23
– – ﹤0.01% 369
2021
Q1 		$19K Buy
23
+2
+10% +$1.54K ﹤0.01% 338
2020
Q4 		$18K Buy
+21
New +$16.2K ﹤0.01% 332

Other funds holding OM

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return
CIP
Champlain Investment Partners Burlington, Vermont $7.88B AUM 6.82% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
B
Braidwell Stamford, Connecticut $3B AUM 46.72% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

Baillie Gifford & Co's OM Position: Q2 2023 in Review

Baillie Gifford & Co sold out of Outset Medical (OM) in Q2 2023, closing a stake of 26 shares — an estimated $7.1K sold.

Baillie Gifford & Co first reported a position in OM in Q4 2020 and held it in 10 quarters. The position peaked at $19K in Q1 2021. 154 funds tracked by Wall St. Rank hold OM as of Q2 2023.

  • Baillie Gifford & Co reported no remaining Outset Medical position as of Q2 2023 after selling out during the quarter.
  • Baillie Gifford & Co sold 26 Outset Medical shares in Q2 2023, an estimated $7.1K.
  • Baillie Gifford & Co first reported a position in Outset Medical in Q4 2020 and held it in 10 quarters.
  • Baillie Gifford & Co's Outset Medical position peaked at $19K in Q1 2021.
  • 154 funds tracked by Wall St. Rank held Outset Medical as of Q2 2023.

Based on Baillie Gifford & Co's 13F filing for Q2 2023, filed 28 Jul 2023.